Dissecting Neuro-Symbolic Quality Assurance for Synthetic Oncology Data Generation
Quick summary
arXiv:2608.22085v1 Announce Type: new Abstract: Synthetic clinical data generation with large language models addresses the scarcity that limits cancer staging research, but oncology hallucinations are categorically harmful: one clinically impossible staging assignment contaminates every downstream model trained on it. Neuro-symbolic pipelines validate during generation, yet the contribution of individual quality-assurance components remains unclear. We report three controlled studies isolating gate necessity, constraint attribution, and retrieval conditionality, holding generation protocol, d
Key takeaways
- arXiv:2608.22085v1 Announce Type: new Abstract: Synthetic clinical data generation with large language models addresses the scarcity that limits cancer staging research, but oncology hallucinations are categorically harmful: one clinically impossible staging assignment contaminates every downstream model trained on it.
- Neuro-symbolic pipelines validate during generation, yet the contribution of individual quality-assurance components remains unclear.
- We report three controlled studies isolating gate necessity, constraint attribution, and retrieval conditionality, holding generation protocol, d
Why it matters
“Dissecting Neuro-Symbolic Quality Assurance for Synthetic Oncology Data Generation” highlights the need for repeatable measurement rather than a single impressive demonstration. Independent validation across datasets and clearly stated limitations determine whether a result can guide product decisions.
Member comments